EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Repurposing Ketamine in the Therapy of Depression and Depression-Related Disorders: Recent Advances and Future Potential

Qianting Deng, Emily Parker, Chongyun Wu, Ling Zhu, Timon Cheng-Yi Liu, Rui Duan, Luodan Yang

Aging and disease · 2025

DOI: 10.14336/ad.2024.0239 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Aging and disease, 2025. Verfasst von Qianting Deng und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Physical Education and Sport Science, South China Normal University, Guangzhou, China. Hauptthemen laut MEDLINE: Ketamine, Antidepressive Agents, Drug Repositioning, Depression. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 340 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Depression represents a prevalent and enduring mental disorder of significant concern within the clinical domain. Extensive research indicates that depression is very complex, with many interconnected pathways involved. Most research related to depression focuses on monoamines, neurotrophic factors, the hypothalamic-pituitary-adrenal axis, tryptophan metabolism, energy metabolism, mitochondrial function, the gut-brain axis, glial cell-mediated inflammation, myelination, homeostasis, and brain neural networks. However, recently, Ketamine, an ionotropic N-methyl-D-aspartate (NMDA) receptor antagonist, has been discovered to have rapid antidepressant effects in patients, leading to novel and successful treatment approaches for mood disorders. This review aims to summarize the latest findings and insights into various signaling pathways and systems observed in depression patients and animal models, providing a more comprehensive view of the neurobiology of anxious-depressive-like behavior. Specifically, it highlights the key mechanisms of ketamine as a rapid-acting antidepressant, aiming to enhance the treatment of neuropsychiatric disorders. Moreover, we discuss the potential of ketamine as a prophylactic or therapeutic intervention for stress-related psychiatric disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetamineAntidepressive AgentsDrug RepositioningDepressionDepressive DisorderHumansAnimals

Substanzen

KetamineAntidepressive Agents

Autor:innen und Institutionen

  • College of Physical Education and Sport Science, South China Normal University, Guangzhou, China.
  • Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.

Zitieren

APA

Deng, Q., Parker, E., Wu, C., Zhu, L., Liu, T. C., Duan, R., & Yang, L. (2025). Repurposing Ketamine in the Therapy of Depression and Depression-Related Disorders: Recent Advances and Future Potential. Aging and disease. https://doi.org/10.14336/ad.2024.0239

Vancouver

Deng Q, Parker E, Wu C, Zhu L, Liu TC, Duan R, et al. Repurposing Ketamine in the Therapy of Depression and Depression-Related Disorders: Recent Advances and Future Potential. Aging and disease. 2025. doi:10.14336/ad.2024.0239

BibTeX
@article{Deng2025,
  author = {Deng, Qianting and Parker, Emily and Wu, Chongyun and Zhu, Ling and Liu, Timon Cheng-Yi and Duan, Rui and Yang, Luodan},
  title = {Repurposing Ketamine in the Therapy of Depression and Depression-Related Disorders: Recent Advances and Future Potential},
  journal = {Aging and disease},
  year = {2025},
  doi = {10.14336/ad.2024.0239}
}
Kostenlos starten →